125 related articles for article (PubMed ID: 28839912)
1. A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland.
Radley A; Melville K; Tait J; Stephens B; Evans JMM; Dillon JF
Frontline Gastroenterol; 2017 Jul; 8(3):221-228. PubMed ID: 28839912
[TBL] [Abstract][Full Text] [Related]
2. DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.
Radley A; Tait J; Dillon JF
Int J Drug Policy; 2017 Sep; 47():126-136. PubMed ID: 28647161
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Dillon JF
BMJ Open; 2018 Dec; 8(12):e021443. PubMed ID: 30552244
[TBL] [Abstract][Full Text] [Related]
4. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
5. Application of a discrete choice experiment approach to support the design of a hepatitis C testing service in primary care.
Radley A; van der Pol M; Dillon JF
Int J Drug Policy; 2019 Mar; 65():1-7. PubMed ID: 30576938
[TBL] [Abstract][Full Text] [Related]
6. Assessing the acceptability of dried blood spot testing for HIV and STBBI among Métis people in a community driven pilot project in Alberta, Canada.
Landy R; Atkinson D; Ogilvie K; St Denys R; Lund C; Worthington C;
BMC Health Serv Res; 2022 Dec; 22(1):1496. PubMed ID: 36482470
[TBL] [Abstract][Full Text] [Related]
7. A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons.
Craine N; Whitaker R; Perrett S; Zou L; Hickman M; Lyons M
Eur J Public Health; 2015 Apr; 25(2):351-7. PubMed ID: 25061233
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
9. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
10. Dry blood spot testing for hepatitis C in people who injected drugs: reaching the populations other tests cannot reach.
Tait JM; Stephens BP; McIntyre PG; Evans M; Dillon JF
Frontline Gastroenterol; 2013 Oct; 4(4):255-262. PubMed ID: 28839735
[TBL] [Abstract][Full Text] [Related]
11. Service provision in the wake of a new funding model for community pharmacy.
Smith AJ; Scahill SL; Harrison J; Carroll T; Medlicott NJ
BMC Health Serv Res; 2018 May; 18(1):307. PubMed ID: 29716610
[TBL] [Abstract][Full Text] [Related]
12. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
Gidman W; Coomber R
Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy specialists' attitudes toward pharmaceutical service quality at community pharmacies.
Urbonas G; Jakušovaitė I; Savickas A
Medicina (Kaunas); 2010; 46(10):686-92. PubMed ID: 21393987
[TBL] [Abstract][Full Text] [Related]
14. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
[TBL] [Abstract][Full Text] [Related]
15. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
16. 'Standing Outside the Junkie Door'-service users' experiences of using community pharmacies to access treatment for opioid dependency.
Radley A; Melville K; Easton P; Williams B; Dillon JF
J Public Health (Oxf); 2017 Dec; 39(4):846-855. PubMed ID: 27915259
[TBL] [Abstract][Full Text] [Related]
17. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
[TBL] [Abstract][Full Text] [Related]
18. Implementation study of an intermediate medication review in Belgian community pharmacies.
Lelubre M; Wuyts J; Maesschalck J; Duquet N; Foubert K; Hutsebaut C; Moullin J; De Wulf I; Boussery K; Foulon V; De Vriese C
Res Social Adm Pharm; 2019 Jun; 15(6):710-723. PubMed ID: 30241873
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
Sheridan J; Manning V; Ridge G; Mayet S; Strang J
Addiction; 2007 Nov; 102(11):1824-30. PubMed ID: 17935587
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
